Xylogenics Chief Science Officer to Present at Fuel Ethanol Workshop

Mark Goebl, Ph.D., will discuss Xylogenics' proprietary process to improve the production of cellulosic ethanol through manipulation of yeast. Xylogenics is a bioengineering firm based in Indianapolis.

Xylogenics Chief Science Officer Mark Goebl, Ph.D., will speak in a panel session on "Yield Improvements through Fermentation Advances" at the Fuel Ethanol Workshop in St. Louis on June 16, 2010.

Dr. Goebl's presentation entitled "Cellulosic Ethanol Improved by the Manipulation of Yeast and the Fermentation Environment" will focus on how the Xylogenics technology positively impacts ethanol production by using genetic modifications to improve the conversion of sugar to ethanol. Xylogenics technology will enable ethanol production facilities throughout the U.S. and Canada to boost the fermentation process, increase production efficiency and reduce costs. The Company's proprietary yeast strains can potentially improve fermentation yields by 30 percent or more.

Dr. Goebl is also Professor of Biochemistry at the School of Medicine at Indiana University.

###

Xylogenics is a bioengineering firm based in Indianapolis that develops genetically modified yeast strains to increase the production efficiency of ethanol from biomass. These proprietary yeast strains can potentially boost fermentation yields by 30 to 50 percent in cellulosic ethanol production facilities. Xylogenics patent pending technology increases the amount of cellulosic material converted to ethanol resulting from its proprietary bioengineered yeast strains optimizing yield efficiencies. For more information, visit www.xylogenics.com.

Share:


Tags: BioEngineering, biofuels, biomass, cellulosic ethanol, ethanol, fermentation, green technology, Xylogenics


About Xylogenics

View Website

Mike Neibler
Press Contact, Xylogenics
Xylogenics
351 W. 10th Street
Indianapolis, IN 46202